Topic

Washington

A collection of 516 issues

If Uplizna (Inebilizumab) Isn't Approved by Humana in Washington: Formulary Alternatives & Exception Paths

Quick Answer: Your Options When Humana Denies Uplizna If Humana denies Uplizna (inebilizumab) in Washington, you have three paths: 1) Try preferred alternatives like Ultomiris (ravulizumab) which requires no step therapy, 2) Request a formulary exception with medical necessity documentation, or 3) Appeal the denial through Washington's external

How to Get Spinraza (Nusinersen) Covered by Cigna in Washington: Complete PA Guide with Appeal Scripts

Answer Box: Fast Track to Spinraza Coverage Cigna requires prior authorization for Spinraza (nusinersen) with genetic testing documentation confirming 5q SMA. Submit Cigna's CCRD form via CoverMyMeds with SMN1/SMN2 gene results, neurologist attestation, and clinical notes. Standard approval takes 72 hours; urgent cases get 24-hour decisions. If

Myths vs. Facts: Getting Pyrukynd (Mitapivat) Covered by Cigna in Washington

Quick Answer: Getting Pyrukynd Covered by Cigna in Washington Yes, Cigna covers Pyrukynd (mitapivat) with prior authorization. You need confirmed PKLR gene mutations (≥2 variants, ≥1 missense), hemoglobin ≤10 g/dL OR ≥6 transfusions in 12 months, and a hematologist prescription. If denied, Washington's strong external review process

Myths vs. Facts: Getting Trikafta Covered by Blue Cross Blue Shield in Washington (2025 PA Guide)

Answer Box: Trikafta requires prior authorization from all Blue Cross Blue Shield plans in Washington, including Premera and Regence. Success depends on proper CFTR genotype documentation (F508del mutation), CF specialist attestation, and complete clinical records—not just a prescription. If denied, you have 180 days to appeal and can request

How to Get Jakafi (Ruxolitinib) Covered by UnitedHealthcare in Washington: Complete Guide to Prior Authorization, Appeals, and IRO Review

Answer Box: Getting Jakafi (Ruxolitinib) Covered by UnitedHealthcare in Washington Jakafi (ruxolitinib) requires prior authorization from UnitedHealthcare, but approval is achievable with proper documentation. For myelofibrosis, provide intermediate/high-risk diagnosis evidence and symptom documentation. For polycythemia vera, document hydroxyurea failure or intolerance. Submit via the UnitedHealthcare provider portal with complete

How to Get Vimizim (elosulfase alfa) Covered by Blue Cross Blue Shield in Washington: Appeals Guide & Templates

Quick Answer: Getting Vimizim Covered by Blue Cross Blue Shield in Washington Blue Cross Blue Shield Washington (Premera) requires prior authorization for Vimizim (elosulfase alfa) with specific diagnostic and functional testing requirements. To get coverage: 1) Submit PA request with confirmed MPS IVA diagnosis via GALNS enzyme testing or genetic

Myths vs. Facts: Getting Vyndaqel / Vyndamax (tafamidis) Covered by Blue Cross Blue Shield in Washington

Answer Box: The Reality of Vyndaqel Coverage Myth: If your cardiologist prescribes Vyndaqel/Vyndamax (tafamidis), Blue Cross Blue Shield automatically covers it. Fact: BCBS requires prior authorization with confirmed ATTR-CM diagnosis (PYP scan Grade 2-3, AL amyloidosis ruled out), NYHA Class I-III heart failure, and cardiology oversight. Success depends on

Blue Cross Blue Shield's Coverage Criteria for Zolgensma in Washington: What Counts as "Medically Necessary"?

Answer Box: Getting Zolgensma Covered by Blue Cross Blue Shield in Washington Blue Cross Blue Shield plans in Washington require prior authorization for Zolgensma with strict medical necessity criteria: genetically confirmed SMA with bi-allelic SMN1 mutations, age under 2 years, anti-AAV9 antibody titer ≤1:50, and treatment at an approved

Get Fintepla (fenfluramine) Covered by Cigna in Washington: Complete Prior Authorization Guide with Appeals

Answer Box: Getting Fintepla Covered by Cigna in Washington Fintepla (fenfluramine) requires prior authorization from Cigna for Dravet syndrome or Lennox-Gastaut syndrome patients. Key requirements: confirmed diagnosis with ICD-10 codes G40.833/G40.834 (Dravet) or G40.81 (LGS), documented failure of standard anti-seizure medications, REMS enrollment, and baseline echocardiogram.

How Long Does It Take to Get Defitelio (Defibrotide) Approved by UnitedHealthcare in Washington? Complete Timeline Guide

Quick Answer: UnitedHealthcare typically processes Defitelio (defibrotide) prior authorization requests within 3-7 business days for standard review, or 24-72 hours for expedited cases involving hepatic VOD/SOS after HSCT. In Washington, if denied, you have 180 days to appeal internally, followed by external review through an Independent Review Organization (IRO)